nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR1B—trigeminal nucleus—multiple sclerosis	0.0704	0.156	CbGeAlD
Methysergide—HTR1D—trigeminal nucleus—multiple sclerosis	0.0681	0.151	CbGeAlD
Methysergide—HTR1D—meninx—multiple sclerosis	0.0452	0.1	CbGeAlD
Methysergide—HTR1F—trigeminal nerve—multiple sclerosis	0.0451	0.1	CbGeAlD
Methysergide—HTR2A—trigeminal nucleus—multiple sclerosis	0.0338	0.075	CbGeAlD
Methysergide—HTR1B—trigeminal nerve—multiple sclerosis	0.0185	0.041	CbGeAlD
Methysergide—HTR1D—trigeminal nerve—multiple sclerosis	0.0179	0.0396	CbGeAlD
Methysergide—HTR7—pons—multiple sclerosis	0.01	0.0222	CbGeAlD
Methysergide—HTR2A—trigeminal nerve—multiple sclerosis	0.00889	0.0197	CbGeAlD
Methysergide—HTR7—peripheral nervous system—multiple sclerosis	0.00668	0.0148	CbGeAlD
Methysergide—HTR2A—pons—multiple sclerosis	0.00626	0.0139	CbGeAlD
Methysergide—HTR1E—brainstem—multiple sclerosis	0.00613	0.0136	CbGeAlD
Methysergide—HTR7—nerve—multiple sclerosis	0.00521	0.0115	CbGeAlD
Methysergide—HTR2A—pineal body—multiple sclerosis	0.00447	0.0099	CbGeAlD
Methysergide—HTR2A—peripheral nervous system—multiple sclerosis	0.00416	0.00923	CbGeAlD
Methysergide—HTR1F—nervous system—multiple sclerosis	0.00371	0.00821	CbGeAlD
Methysergide—HTR1F—central nervous system—multiple sclerosis	0.00357	0.0079	CbGeAlD
Methysergide—HTR2A—nerve—multiple sclerosis	0.00325	0.00719	CbGeAlD
Methysergide—HTR1E—nervous system—multiple sclerosis	0.00321	0.00711	CbGeAlD
Methysergide—HTR1E—central nervous system—multiple sclerosis	0.00309	0.00685	CbGeAlD
Methysergide—HTR1B—brainstem—multiple sclerosis	0.0029	0.00642	CbGeAlD
Methysergide—HTR1F—brain—multiple sclerosis	0.00283	0.00628	CbGeAlD
Methysergide—HTR1D—brainstem—multiple sclerosis	0.00281	0.00622	CbGeAlD
Methysergide—HTR2C—brainstem—multiple sclerosis	0.00278	0.00616	CbGeAlD
Methysergide—HTR6—nervous system—multiple sclerosis	0.00252	0.00558	CbGeAlD
Methysergide—HTR1E—brain—multiple sclerosis	0.00245	0.00544	CbGeAlD
Methysergide—HTR6—central nervous system—multiple sclerosis	0.00243	0.00537	CbGeAlD
Methysergide—HTR1A—brainstem—multiple sclerosis	0.00234	0.00518	CbGeAlD
Methysergide—HTR7—brainstem—multiple sclerosis	0.00223	0.00495	CbGeAlD
Methysergide—HTR2C—medulla oblongata—multiple sclerosis	0.00194	0.00429	CbGeAlD
Methysergide—HTR6—brain—multiple sclerosis	0.00193	0.00427	CbGeAlD
Methysergide—HTR1B—midbrain—multiple sclerosis	0.00185	0.00409	CbGeAlD
Methysergide—SIGMAR1—medulla oblongata—multiple sclerosis	0.00182	0.00404	CbGeAlD
Methysergide—HTR1B—spinal cord—multiple sclerosis	0.0018	0.00399	CbGeAlD
Methysergide—HTR1D—midbrain—multiple sclerosis	0.00179	0.00396	CbGeAlD
Methysergide—HTR2C—midbrain—multiple sclerosis	0.00177	0.00392	CbGeAlD
Methysergide—HTR2C—spinal cord—multiple sclerosis	0.00173	0.00383	CbGeAlD
Methysergide—SIGMAR1—midbrain—multiple sclerosis	0.00167	0.00369	CbGeAlD
Methysergide—SIGMAR1—spinal cord—multiple sclerosis	0.00163	0.0036	CbGeAlD
Methysergide—HTR7—medulla oblongata—multiple sclerosis	0.00156	0.00345	CbGeAlD
Methysergide—HTR1B—nervous system—multiple sclerosis	0.00152	0.00336	CbGeAlD
Methysergide—HTR1A—midbrain—multiple sclerosis	0.00149	0.0033	CbGeAlD
Methysergide—HTR1D—nervous system—multiple sclerosis	0.00147	0.00326	CbGeAlD
Methysergide—HTR1B—central nervous system—multiple sclerosis	0.00146	0.00324	CbGeAlD
Methysergide—HTR2C—nervous system—multiple sclerosis	0.00146	0.00322	CbGeAlD
Methysergide—HTR1A—spinal cord—multiple sclerosis	0.00145	0.00322	CbGeAlD
Methysergide—HTR7—midbrain—multiple sclerosis	0.00142	0.00316	CbGeAlD
Methysergide—HTR1D—central nervous system—multiple sclerosis	0.00142	0.00314	CbGeAlD
Methysergide—HTR2C—central nervous system—multiple sclerosis	0.0014	0.0031	CbGeAlD
Methysergide—HTR2A—brainstem—multiple sclerosis	0.00139	0.00309	CbGeAlD
Methysergide—HTR7—spinal cord—multiple sclerosis	0.00139	0.00308	CbGeAlD
Methysergide—HTR2B—nervous system—multiple sclerosis	0.00137	0.00303	CbGeAlD
Methysergide—HTR2A—retina—multiple sclerosis	0.00134	0.00298	CbGeAlD
Methysergide—HTR2B—central nervous system—multiple sclerosis	0.00132	0.00292	CbGeAlD
Methysergide—SIGMAR1—cerebellum—multiple sclerosis	0.00129	0.00286	CbGeAlD
Methysergide—Somnolence—Cladribine—multiple sclerosis	0.00125	0.00405	CcSEcCtD
Methysergide—HTR1A—nervous system—multiple sclerosis	0.00123	0.00271	CbGeAlD
Methysergide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00121	0.00393	CcSEcCtD
Methysergide—Weight increased—Prednisolone—multiple sclerosis	0.00121	0.00393	CcSEcCtD
Methysergide—Fatigue—Cladribine—multiple sclerosis	0.00121	0.00393	CcSEcCtD
Methysergide—Constipation—Cladribine—multiple sclerosis	0.0012	0.0039	CcSEcCtD
Methysergide—Pain—Cladribine—multiple sclerosis	0.0012	0.0039	CcSEcCtD
Methysergide—Myalgia—Azathioprine—multiple sclerosis	0.00119	0.00387	CcSEcCtD
Methysergide—Arthralgia—Azathioprine—multiple sclerosis	0.00119	0.00387	CcSEcCtD
Methysergide—HTR1A—central nervous system—multiple sclerosis	0.00118	0.00261	CbGeAlD
Methysergide—Discomfort—Azathioprine—multiple sclerosis	0.00118	0.00382	CcSEcCtD
Methysergide—HTR7—nervous system—multiple sclerosis	0.00117	0.00259	CbGeAlD
Methysergide—Urine output increased—Methotrexate—multiple sclerosis	0.00116	0.00378	CcSEcCtD
Methysergide—HTR1B—brain—multiple sclerosis	0.00116	0.00257	CbGeAlD
Methysergide—Feeling abnormal—Cladribine—multiple sclerosis	0.00116	0.00376	CcSEcCtD
Methysergide—HTR1A—cerebellum—multiple sclerosis	0.00115	0.00255	CbGeAlD
Methysergide—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00115	0.00373	CcSEcCtD
Methysergide—Alopecia—Mitoxantrone—multiple sclerosis	0.00115	0.00373	CcSEcCtD
Methysergide—HTR7—central nervous system—multiple sclerosis	0.00113	0.0025	CbGeAlD
Methysergide—HTR1D—brain—multiple sclerosis	0.00112	0.00249	CbGeAlD
Methysergide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.00112	0.00363	CcSEcCtD
Methysergide—Weight increased—Triamcinolone—multiple sclerosis	0.00111	0.00362	CcSEcCtD
Methysergide—HTR2C—brain—multiple sclerosis	0.00111	0.00246	CbGeAlD
Methysergide—Weight increased—Methylprednisolone—multiple sclerosis	0.00111	0.00361	CcSEcCtD
Methysergide—Abdominal pain—Cladribine—multiple sclerosis	0.00111	0.0036	CcSEcCtD
Methysergide—Body temperature increased—Cladribine—multiple sclerosis	0.00111	0.0036	CcSEcCtD
Methysergide—HTR7—cerebellum—multiple sclerosis	0.0011	0.00244	CbGeAlD
Methysergide—Back pain—Mitoxantrone—multiple sclerosis	0.00109	0.00355	CcSEcCtD
Methysergide—Thrombophlebitis—Methotrexate—multiple sclerosis	0.00108	0.00351	CcSEcCtD
Methysergide—Polyuria—Methotrexate—multiple sclerosis	0.00106	0.00346	CcSEcCtD
Methysergide—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.00105	0.00341	CcSEcCtD
Methysergide—SIGMAR1—brain—multiple sclerosis	0.00105	0.00232	CbGeAlD
Methysergide—HTR2B—brain—multiple sclerosis	0.00105	0.00232	CbGeAlD
Methysergide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00104	0.00338	CcSEcCtD
Methysergide—Malaise—Mitoxantrone—multiple sclerosis	0.00102	0.00331	CcSEcCtD
Methysergide—Weight increased—Betamethasone—multiple sclerosis	0.00101	0.00328	CcSEcCtD
Methysergide—Weight increased—Dexamethasone—multiple sclerosis	0.00101	0.00328	CcSEcCtD
Methysergide—Asthenia—Cladribine—multiple sclerosis	0.00101	0.00327	CcSEcCtD
Methysergide—Weight decreased—Dexamethasone—multiple sclerosis	0.001	0.00326	CcSEcCtD
Methysergide—Weight decreased—Betamethasone—multiple sclerosis	0.001	0.00326	CcSEcCtD
Methysergide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000985	0.0032	CcSEcCtD
Methysergide—Convulsion—Mitoxantrone—multiple sclerosis	0.000979	0.00318	CcSEcCtD
Methysergide—HTR2A—medulla oblongata—multiple sclerosis	0.000972	0.00215	CbGeAlD
Methysergide—Chest pain—Mitoxantrone—multiple sclerosis	0.000962	0.00312	CcSEcCtD
Methysergide—Arthralgia—Mitoxantrone—multiple sclerosis	0.000962	0.00312	CcSEcCtD
Methysergide—Myalgia—Mitoxantrone—multiple sclerosis	0.000962	0.00312	CcSEcCtD
Methysergide—Diarrhoea—Cladribine—multiple sclerosis	0.00096	0.00312	CcSEcCtD
Methysergide—Discomfort—Mitoxantrone—multiple sclerosis	0.000951	0.00309	CcSEcCtD
Methysergide—Feeling abnormal—Azathioprine—multiple sclerosis	0.00094	0.00305	CcSEcCtD
Methysergide—HTR1A—brain—multiple sclerosis	0.000936	0.00207	CbGeAlD
Methysergide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000933	0.00303	CcSEcCtD
Methysergide—Dizziness—Cladribine—multiple sclerosis	0.000928	0.00301	CcSEcCtD
Methysergide—Oedema—Mitoxantrone—multiple sclerosis	0.000922	0.003	CcSEcCtD
Methysergide—Neutropenia—Prednisone—multiple sclerosis	0.000904	0.00294	CcSEcCtD
Methysergide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000903	0.00293	CcSEcCtD
Methysergide—Abdominal pain—Azathioprine—multiple sclerosis	0.000902	0.00293	CcSEcCtD
Methysergide—Body temperature increased—Azathioprine—multiple sclerosis	0.000902	0.00293	CcSEcCtD
Methysergide—Tachycardia—Mitoxantrone—multiple sclerosis	0.0009	0.00292	CcSEcCtD
Methysergide—HTR7—brain—multiple sclerosis	0.000895	0.00198	CbGeAlD
Methysergide—Vomiting—Cladribine—multiple sclerosis	0.000892	0.0029	CcSEcCtD
Methysergide—HTR2A—midbrain—multiple sclerosis	0.000888	0.00197	CbGeAlD
Methysergide—Rash—Cladribine—multiple sclerosis	0.000885	0.00287	CcSEcCtD
Methysergide—Dermatitis—Cladribine—multiple sclerosis	0.000884	0.00287	CcSEcCtD
Methysergide—Weight increased—Prednisone—multiple sclerosis	0.00088	0.00286	CcSEcCtD
Methysergide—Ataxia—Methotrexate—multiple sclerosis	0.000879	0.00286	CcSEcCtD
Methysergide—Weight decreased—Prednisone—multiple sclerosis	0.000875	0.00284	CcSEcCtD
Methysergide—HTR2A—spinal cord—multiple sclerosis	0.000867	0.00192	CbGeAlD
Methysergide—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00086	0.00279	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00084	0.00273	CcSEcCtD
Methysergide—Malaise—Prednisolone—multiple sclerosis	0.000836	0.00272	CcSEcCtD
Methysergide—Nausea—Cladribine—multiple sclerosis	0.000833	0.00271	CcSEcCtD
Methysergide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000828	0.00269	CcSEcCtD
Methysergide—Back pain—Triamcinolone—multiple sclerosis	0.000825	0.00268	CcSEcCtD
Methysergide—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000822	0.00267	CcSEcCtD
Methysergide—Somnolence—Mitoxantrone—multiple sclerosis	0.00082	0.00266	CcSEcCtD
Methysergide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000812	0.00264	CcSEcCtD
Methysergide—Convulsion—Prednisolone—multiple sclerosis	0.000803	0.00261	CcSEcCtD
Methysergide—Eosinophilia—Methotrexate—multiple sclerosis	0.0008	0.0026	CcSEcCtD
Methysergide—Fatigue—Mitoxantrone—multiple sclerosis	0.000795	0.00258	CcSEcCtD
Methysergide—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000791	0.00257	CcSEcCtD
Methysergide—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000789	0.00256	CcSEcCtD
Methysergide—Pain—Mitoxantrone—multiple sclerosis	0.000789	0.00256	CcSEcCtD
Methysergide—Constipation—Mitoxantrone—multiple sclerosis	0.000789	0.00256	CcSEcCtD
Methysergide—Alopecia—Dexamethasone—multiple sclerosis	0.000785	0.00255	CcSEcCtD
Methysergide—Alopecia—Betamethasone—multiple sclerosis	0.000785	0.00255	CcSEcCtD
Methysergide—Diarrhoea—Azathioprine—multiple sclerosis	0.000781	0.00254	CcSEcCtD
Methysergide—Discomfort—Prednisolone—multiple sclerosis	0.00078	0.00253	CcSEcCtD
Methysergide—Malaise—Triamcinolone—multiple sclerosis	0.000769	0.0025	CcSEcCtD
Methysergide—Malaise—Methylprednisolone—multiple sclerosis	0.000767	0.00249	CcSEcCtD
Methysergide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00076	0.00247	CcSEcCtD
Methysergide—Oedema—Prednisolone—multiple sclerosis	0.000757	0.00246	CcSEcCtD
Methysergide—Neutropenia—Methotrexate—multiple sclerosis	0.000756	0.00245	CcSEcCtD
Methysergide—Dysuria—Methotrexate—multiple sclerosis	0.000756	0.00245	CcSEcCtD
Methysergide—Dizziness—Azathioprine—multiple sclerosis	0.000754	0.00245	CcSEcCtD
Methysergide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000754	0.00245	CcSEcCtD
Methysergide—Convulsion—Triamcinolone—multiple sclerosis	0.000739	0.0024	CcSEcCtD
Methysergide—Tachycardia—Prednisolone—multiple sclerosis	0.000739	0.0024	CcSEcCtD
Methysergide—Convulsion—Methylprednisolone—multiple sclerosis	0.000737	0.00239	CcSEcCtD
Methysergide—HTR2A—nervous system—multiple sclerosis	0.00073	0.00162	CbGeAlD
Methysergide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000729	0.00237	CcSEcCtD
Methysergide—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000729	0.00237	CcSEcCtD
Methysergide—Myalgia—Triamcinolone—multiple sclerosis	0.000726	0.00236	CcSEcCtD
Methysergide—Vomiting—Azathioprine—multiple sclerosis	0.000725	0.00236	CcSEcCtD
Methysergide—Arthralgia—Methylprednisolone—multiple sclerosis	0.000724	0.00235	CcSEcCtD
Methysergide—Myalgia—Methylprednisolone—multiple sclerosis	0.000724	0.00235	CcSEcCtD
Methysergide—Drowsiness—Methotrexate—multiple sclerosis	0.000721	0.00234	CcSEcCtD
Methysergide—Rash—Azathioprine—multiple sclerosis	0.000719	0.00234	CcSEcCtD
Methysergide—Dermatitis—Azathioprine—multiple sclerosis	0.000719	0.00233	CcSEcCtD
Methysergide—Flushing—Prednisone—multiple sclerosis	0.000718	0.00233	CcSEcCtD
Methysergide—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000718	0.00233	CcSEcCtD
Methysergide—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000718	0.00233	CcSEcCtD
Methysergide—Discomfort—Triamcinolone—multiple sclerosis	0.000717	0.00233	CcSEcCtD
Methysergide—Discomfort—Methylprednisolone—multiple sclerosis	0.000716	0.00232	CcSEcCtD
Methysergide—HTR2A—central nervous system—multiple sclerosis	0.000703	0.00156	CbGeAlD
Methysergide—Malaise—Dexamethasone—multiple sclerosis	0.000698	0.00227	CcSEcCtD
Methysergide—Malaise—Betamethasone—multiple sclerosis	0.000698	0.00227	CcSEcCtD
Methysergide—Oedema—Triamcinolone—multiple sclerosis	0.000696	0.00226	CcSEcCtD
Methysergide—HTR2A—cerebellum—multiple sclerosis	0.000687	0.00152	CbGeAlD
Methysergide—Insomnia—Prednisolone—multiple sclerosis	0.000684	0.00222	CcSEcCtD
Methysergide—Alopecia—Prednisone—multiple sclerosis	0.000684	0.00222	CcSEcCtD
Methysergide—Paraesthesia—Prednisolone—multiple sclerosis	0.000679	0.00221	CcSEcCtD
Methysergide—Tachycardia—Triamcinolone—multiple sclerosis	0.000679	0.00221	CcSEcCtD
Methysergide—Nausea—Azathioprine—multiple sclerosis	0.000678	0.0022	CcSEcCtD
Methysergide—Tachycardia—Methylprednisolone—multiple sclerosis	0.000678	0.0022	CcSEcCtD
Methysergide—Convulsion—Dexamethasone—multiple sclerosis	0.00067	0.00218	CcSEcCtD
Methysergide—Convulsion—Betamethasone—multiple sclerosis	0.00067	0.00218	CcSEcCtD
Methysergide—Asthenia—Mitoxantrone—multiple sclerosis	0.000662	0.00215	CcSEcCtD
Methysergide—Myalgia—Betamethasone—multiple sclerosis	0.000659	0.00214	CcSEcCtD
Methysergide—Myalgia—Dexamethasone—multiple sclerosis	0.000659	0.00214	CcSEcCtD
Methysergide—Discomfort—Betamethasone—multiple sclerosis	0.000651	0.00211	CcSEcCtD
Methysergide—Discomfort—Dexamethasone—multiple sclerosis	0.000651	0.00211	CcSEcCtD
Methysergide—Pain—Prednisolone—multiple sclerosis	0.000647	0.0021	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000634	0.00206	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000633	0.00205	CcSEcCtD
Methysergide—Oedema—Betamethasone—multiple sclerosis	0.000631	0.00205	CcSEcCtD
Methysergide—Oedema—Dexamethasone—multiple sclerosis	0.000631	0.00205	CcSEcCtD
Methysergide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000631	0.00205	CcSEcCtD
Methysergide—Insomnia—Triamcinolone—multiple sclerosis	0.000629	0.00204	CcSEcCtD
Methysergide—Insomnia—Methylprednisolone—multiple sclerosis	0.000628	0.00204	CcSEcCtD
Methysergide—Ill-defined disorder—Prednisone—multiple sclerosis	0.000625	0.00203	CcSEcCtD
Methysergide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000625	0.00203	CcSEcCtD
Methysergide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000624	0.00202	CcSEcCtD
Methysergide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000623	0.00202	CcSEcCtD
Methysergide—Dyspnoea—Triamcinolone—multiple sclerosis	0.00062	0.00201	CcSEcCtD
Methysergide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000618	0.00201	CcSEcCtD
Methysergide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000618	0.00201	CcSEcCtD
Methysergide—Tachycardia—Dexamethasone—multiple sclerosis	0.000616	0.002	CcSEcCtD
Methysergide—Tachycardia—Betamethasone—multiple sclerosis	0.000616	0.002	CcSEcCtD
Methysergide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000613	0.00199	CcSEcCtD
Methysergide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000611	0.00198	CcSEcCtD
Methysergide—Malaise—Prednisone—multiple sclerosis	0.000608	0.00197	CcSEcCtD
Methysergide—Fatigue—Triamcinolone—multiple sclerosis	0.0006	0.00195	CcSEcCtD
Methysergide—Fatigue—Methylprednisolone—multiple sclerosis	0.000599	0.00194	CcSEcCtD
Methysergide—Pain—Triamcinolone—multiple sclerosis	0.000595	0.00193	CcSEcCtD
Methysergide—Vomiting—Mitoxantrone—multiple sclerosis	0.000586	0.0019	CcSEcCtD
Methysergide—Convulsion—Prednisone—multiple sclerosis	0.000584	0.0019	CcSEcCtD
Methysergide—Rash—Mitoxantrone—multiple sclerosis	0.000582	0.00189	CcSEcCtD
Methysergide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000581	0.00189	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000575	0.00187	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000575	0.00187	CcSEcCtD
Methysergide—Arthralgia—Prednisone—multiple sclerosis	0.000574	0.00186	CcSEcCtD
Methysergide—Myalgia—Prednisone—multiple sclerosis	0.000574	0.00186	CcSEcCtD
Methysergide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000573	0.00186	CcSEcCtD
Methysergide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000572	0.00186	CcSEcCtD
Methysergide—Alopecia—Methotrexate—multiple sclerosis	0.000572	0.00186	CcSEcCtD
Methysergide—Insomnia—Dexamethasone—multiple sclerosis	0.000571	0.00185	CcSEcCtD
Methysergide—Insomnia—Betamethasone—multiple sclerosis	0.000571	0.00185	CcSEcCtD
Methysergide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000568	0.00184	CcSEcCtD
Methysergide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000567	0.00184	CcSEcCtD
Methysergide—Paraesthesia—Betamethasone—multiple sclerosis	0.000567	0.00184	CcSEcCtD
Methysergide—Discomfort—Prednisone—multiple sclerosis	0.000567	0.00184	CcSEcCtD
Methysergide—HTR2A—brain—multiple sclerosis	0.000558	0.00124	CbGeAlD
Methysergide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000556	0.0018	CcSEcCtD
Methysergide—Dyspepsia—Betamethasone—multiple sclerosis	0.000556	0.0018	CcSEcCtD
Methysergide—Body temperature increased—Triamcinolone—multiple sclerosis	0.00055	0.00179	CcSEcCtD
Methysergide—Oedema—Prednisone—multiple sclerosis	0.00055	0.00179	CcSEcCtD
Methysergide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000549	0.00178	CcSEcCtD
Methysergide—Nausea—Mitoxantrone—multiple sclerosis	0.000548	0.00178	CcSEcCtD
Methysergide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000545	0.00177	CcSEcCtD
Methysergide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000545	0.00177	CcSEcCtD
Methysergide—Back pain—Methotrexate—multiple sclerosis	0.000545	0.00177	CcSEcCtD
Methysergide—Fatigue—Betamethasone—multiple sclerosis	0.000544	0.00177	CcSEcCtD
Methysergide—Fatigue—Dexamethasone—multiple sclerosis	0.000544	0.00177	CcSEcCtD
Methysergide—Pain—Betamethasone—multiple sclerosis	0.00054	0.00175	CcSEcCtD
Methysergide—Pain—Dexamethasone—multiple sclerosis	0.00054	0.00175	CcSEcCtD
Methysergide—Tachycardia—Prednisone—multiple sclerosis	0.000537	0.00174	CcSEcCtD
Methysergide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000522	0.0017	CcSEcCtD
Methysergide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00052	0.00169	CcSEcCtD
Methysergide—Feeling abnormal—Betamethasone—multiple sclerosis	0.00052	0.00169	CcSEcCtD
Methysergide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000516	0.00168	CcSEcCtD
Methysergide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000516	0.00168	CcSEcCtD
Methysergide—Malaise—Methotrexate—multiple sclerosis	0.000508	0.00165	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000501	0.00163	CcSEcCtD
Methysergide—Dizziness—Prednisolone—multiple sclerosis	0.0005	0.00162	CcSEcCtD
Methysergide—Asthenia—Triamcinolone—multiple sclerosis	0.000499	0.00162	CcSEcCtD
Methysergide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000499	0.00162	CcSEcCtD
Methysergide—Abdominal pain—Betamethasone—multiple sclerosis	0.000499	0.00162	CcSEcCtD
Methysergide—Body temperature increased—Betamethasone—multiple sclerosis	0.000499	0.00162	CcSEcCtD
Methysergide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000499	0.00162	CcSEcCtD
Methysergide—Asthenia—Methylprednisolone—multiple sclerosis	0.000498	0.00162	CcSEcCtD
Methysergide—Insomnia—Prednisone—multiple sclerosis	0.000497	0.00162	CcSEcCtD
Methysergide—Paraesthesia—Prednisone—multiple sclerosis	0.000494	0.0016	CcSEcCtD
Methysergide—Convulsion—Methotrexate—multiple sclerosis	0.000488	0.00158	CcSEcCtD
Methysergide—Dyspepsia—Prednisone—multiple sclerosis	0.000484	0.00157	CcSEcCtD
Methysergide—Arthralgia—Methotrexate—multiple sclerosis	0.000479	0.00156	CcSEcCtD
Methysergide—Chest pain—Methotrexate—multiple sclerosis	0.000479	0.00156	CcSEcCtD
Methysergide—Myalgia—Methotrexate—multiple sclerosis	0.000479	0.00156	CcSEcCtD
Methysergide—Rash—Prednisolone—multiple sclerosis	0.000477	0.00155	CcSEcCtD
Methysergide—Dermatitis—Prednisolone—multiple sclerosis	0.000477	0.00155	CcSEcCtD
Methysergide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000475	0.00154	CcSEcCtD
Methysergide—Fatigue—Prednisone—multiple sclerosis	0.000474	0.00154	CcSEcCtD
Methysergide—Discomfort—Methotrexate—multiple sclerosis	0.000474	0.00154	CcSEcCtD
Methysergide—Constipation—Prednisone—multiple sclerosis	0.00047	0.00153	CcSEcCtD
Methysergide—Dizziness—Triamcinolone—multiple sclerosis	0.00046	0.00149	CcSEcCtD
Methysergide—Dizziness—Methylprednisolone—multiple sclerosis	0.000459	0.00149	CcSEcCtD
Methysergide—Feeling abnormal—Prednisone—multiple sclerosis	0.000453	0.00147	CcSEcCtD
Methysergide—Asthenia—Betamethasone—multiple sclerosis	0.000453	0.00147	CcSEcCtD
Methysergide—Asthenia—Dexamethasone—multiple sclerosis	0.000453	0.00147	CcSEcCtD
Methysergide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00045	0.00146	CcSEcCtD
Methysergide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00045	0.00146	CcSEcCtD
Methysergide—Nausea—Prednisolone—multiple sclerosis	0.000449	0.00146	CcSEcCtD
Methysergide—Vomiting—Triamcinolone—multiple sclerosis	0.000442	0.00144	CcSEcCtD
Methysergide—Vomiting—Methylprednisolone—multiple sclerosis	0.000441	0.00143	CcSEcCtD
Methysergide—Rash—Triamcinolone—multiple sclerosis	0.000439	0.00142	CcSEcCtD
Methysergide—Dermatitis—Triamcinolone—multiple sclerosis	0.000438	0.00142	CcSEcCtD
Methysergide—Rash—Methylprednisolone—multiple sclerosis	0.000438	0.00142	CcSEcCtD
Methysergide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000437	0.00142	CcSEcCtD
Methysergide—Abdominal pain—Prednisone—multiple sclerosis	0.000435	0.00141	CcSEcCtD
Methysergide—Body temperature increased—Prednisone—multiple sclerosis	0.000435	0.00141	CcSEcCtD
Methysergide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000432	0.0014	CcSEcCtD
Methysergide—Diarrhoea—Betamethasone—multiple sclerosis	0.000432	0.0014	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000419	0.00136	CcSEcCtD
Methysergide—Dizziness—Dexamethasone—multiple sclerosis	0.000418	0.00136	CcSEcCtD
Methysergide—Dizziness—Betamethasone—multiple sclerosis	0.000418	0.00136	CcSEcCtD
Methysergide—Insomnia—Methotrexate—multiple sclerosis	0.000416	0.00135	CcSEcCtD
Methysergide—Nausea—Triamcinolone—multiple sclerosis	0.000413	0.00134	CcSEcCtD
Methysergide—Paraesthesia—Methotrexate—multiple sclerosis	0.000413	0.00134	CcSEcCtD
Methysergide—Nausea—Methylprednisolone—multiple sclerosis	0.000412	0.00134	CcSEcCtD
Methysergide—Dyspnoea—Methotrexate—multiple sclerosis	0.00041	0.00133	CcSEcCtD
Methysergide—Somnolence—Methotrexate—multiple sclerosis	0.000409	0.00133	CcSEcCtD
Methysergide—Dyspepsia—Methotrexate—multiple sclerosis	0.000405	0.00131	CcSEcCtD
Methysergide—Vomiting—Dexamethasone—multiple sclerosis	0.000401	0.0013	CcSEcCtD
Methysergide—Vomiting—Betamethasone—multiple sclerosis	0.000401	0.0013	CcSEcCtD
Methysergide—Rash—Dexamethasone—multiple sclerosis	0.000398	0.00129	CcSEcCtD
Methysergide—Rash—Betamethasone—multiple sclerosis	0.000398	0.00129	CcSEcCtD
Methysergide—Dermatitis—Betamethasone—multiple sclerosis	0.000398	0.00129	CcSEcCtD
Methysergide—Dermatitis—Dexamethasone—multiple sclerosis	0.000398	0.00129	CcSEcCtD
Methysergide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000397	0.00129	CcSEcCtD
Methysergide—Fatigue—Methotrexate—multiple sclerosis	0.000396	0.00129	CcSEcCtD
Methysergide—Asthenia—Prednisone—multiple sclerosis	0.000395	0.00128	CcSEcCtD
Methysergide—Pain—Methotrexate—multiple sclerosis	0.000393	0.00128	CcSEcCtD
Methysergide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000379	0.00123	CcSEcCtD
Methysergide—Diarrhoea—Prednisone—multiple sclerosis	0.000376	0.00122	CcSEcCtD
Methysergide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000376	0.00122	CcSEcCtD
Methysergide—Nausea—Dexamethasone—multiple sclerosis	0.000375	0.00122	CcSEcCtD
Methysergide—Nausea—Betamethasone—multiple sclerosis	0.000375	0.00122	CcSEcCtD
Methysergide—Dizziness—Prednisone—multiple sclerosis	0.000364	0.00118	CcSEcCtD
Methysergide—Abdominal pain—Methotrexate—multiple sclerosis	0.000363	0.00118	CcSEcCtD
Methysergide—Body temperature increased—Methotrexate—multiple sclerosis	0.000363	0.00118	CcSEcCtD
Methysergide—Vomiting—Prednisone—multiple sclerosis	0.00035	0.00114	CcSEcCtD
Methysergide—Rash—Prednisone—multiple sclerosis	0.000347	0.00113	CcSEcCtD
Methysergide—Dermatitis—Prednisone—multiple sclerosis	0.000346	0.00112	CcSEcCtD
Methysergide—Asthenia—Methotrexate—multiple sclerosis	0.00033	0.00107	CcSEcCtD
Methysergide—Nausea—Prednisone—multiple sclerosis	0.000327	0.00106	CcSEcCtD
Methysergide—Diarrhoea—Methotrexate—multiple sclerosis	0.000314	0.00102	CcSEcCtD
Methysergide—Dizziness—Methotrexate—multiple sclerosis	0.000304	0.000987	CcSEcCtD
Methysergide—Vomiting—Methotrexate—multiple sclerosis	0.000292	0.000949	CcSEcCtD
Methysergide—Rash—Methotrexate—multiple sclerosis	0.00029	0.000941	CcSEcCtD
Methysergide—Dermatitis—Methotrexate—multiple sclerosis	0.000289	0.00094	CcSEcCtD
Methysergide—Nausea—Methotrexate—multiple sclerosis	0.000273	0.000886	CcSEcCtD
Methysergide—HTR1F—Signaling Pathways—CD80—multiple sclerosis	5.9e-05	0.000245	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	5.87e-05	0.000244	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	5.87e-05	0.000244	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	5.84e-05	0.000243	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	5.81e-05	0.000241	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	5.79e-05	0.000241	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	5.79e-05	0.000241	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	5.76e-05	0.000239	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	5.71e-05	0.000237	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	5.68e-05	0.000236	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	5.65e-05	0.000235	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	5.62e-05	0.000234	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—POMC—multiple sclerosis	5.6e-05	0.000233	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	5.58e-05	0.000232	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PGR—multiple sclerosis	5.56e-05	0.000231	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CD80—multiple sclerosis	5.56e-05	0.000231	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	5.55e-05	0.000231	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PGR—multiple sclerosis	5.53e-05	0.00023	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	5.51e-05	0.000229	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CCL2—multiple sclerosis	5.48e-05	0.000228	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	5.46e-05	0.000227	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	5.46e-05	0.000227	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	5.44e-05	0.000226	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—TYK2—multiple sclerosis	5.43e-05	0.000226	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	5.43e-05	0.000226	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	5.43e-05	0.000226	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—TYK2—multiple sclerosis	5.43e-05	0.000225	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CD28—multiple sclerosis	5.4e-05	0.000225	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	5.39e-05	0.000224	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CD28—multiple sclerosis	5.38e-05	0.000223	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—MAPK1—multiple sclerosis	5.36e-05	0.000223	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	5.31e-05	0.000221	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—POMC—multiple sclerosis	5.29e-05	0.00022	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	5.28e-05	0.000219	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	5.28e-05	0.000219	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CD86—multiple sclerosis	5.21e-05	0.000216	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CD86—multiple sclerosis	5.2e-05	0.000216	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CCL2—multiple sclerosis	5.17e-05	0.000215	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CD86—multiple sclerosis	5.17e-05	0.000215	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCL5—multiple sclerosis	5.13e-05	0.000213	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCL5—multiple sclerosis	5.12e-05	0.000213	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	5.09e-05	0.000211	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	5.07e-05	0.000211	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CD86—multiple sclerosis	5.06e-05	0.00021	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—MAPK1—multiple sclerosis	5.06e-05	0.00021	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	5e-05	0.000208	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	4.98e-05	0.000207	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	4.98e-05	0.000207	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TYK2—multiple sclerosis	4.98e-05	0.000207	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—IL2—multiple sclerosis	4.98e-05	0.000207	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—IL2—multiple sclerosis	4.97e-05	0.000207	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	4.96e-05	0.000206	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	4.96e-05	0.000206	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	4.94e-05	0.000205	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	4.93e-05	0.000205	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	4.9e-05	0.000204	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	4.88e-05	0.000203	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	4.87e-05	0.000202	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	4.84e-05	0.000201	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PGR—multiple sclerosis	4.81e-05	0.0002	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CD86—multiple sclerosis	4.76e-05	0.000198	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SPP1—multiple sclerosis	4.75e-05	0.000197	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SPP1—multiple sclerosis	4.74e-05	0.000197	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	4.71e-05	0.000196	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	4.71e-05	0.000196	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TYK2—multiple sclerosis	4.7e-05	0.000195	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	4.68e-05	0.000195	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CD28—multiple sclerosis	4.67e-05	0.000194	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCR5—multiple sclerosis	4.62e-05	0.000192	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	4.62e-05	0.000192	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCR5—multiple sclerosis	4.62e-05	0.000192	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	4.59e-05	0.000191	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	4.59e-05	0.000191	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL2RA—multiple sclerosis	4.55e-05	0.000189	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL2RA—multiple sclerosis	4.55e-05	0.000189	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	4.54e-05	0.000189	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	4.52e-05	0.000188	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL2—multiple sclerosis	4.52e-05	0.000188	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	4.52e-05	0.000188	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL2—multiple sclerosis	4.51e-05	0.000188	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	4.5e-05	0.000187	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	4.49e-05	0.000187	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	4.48e-05	0.000186	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	4.43e-05	0.000184	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	4.42e-05	0.000184	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	4.41e-05	0.000183	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	4.4e-05	0.000183	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	4.39e-05	0.000182	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	4.39e-05	0.000182	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	4.34e-05	0.00018	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	4.3e-05	0.000179	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	4.23e-05	0.000176	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	4.22e-05	0.000175	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—APOE—multiple sclerosis	4.2e-05	0.000175	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—APOE—multiple sclerosis	4.2e-05	0.000174	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—APOE—multiple sclerosis	4.17e-05	0.000173	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	4.16e-05	0.000173	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL2—multiple sclerosis	4.14e-05	0.000172	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	4.13e-05	0.000171	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL6—multiple sclerosis	4.12e-05	0.000171	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—APOE—multiple sclerosis	4.08e-05	0.00017	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	4.02e-05	0.000167	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	4e-05	0.000166	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MMP9—multiple sclerosis	3.92e-05	0.000163	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	3.91e-05	0.000162	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL2—multiple sclerosis	3.91e-05	0.000162	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL6—multiple sclerosis	3.89e-05	0.000162	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CD86—multiple sclerosis	3.86e-05	0.00016	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—APOE—multiple sclerosis	3.84e-05	0.000159	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CD86—multiple sclerosis	3.84e-05	0.000159	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	3.82e-05	0.000159	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	3.81e-05	0.000158	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CD80—multiple sclerosis	3.8e-05	0.000158	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	3.8e-05	0.000158	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CD80—multiple sclerosis	3.8e-05	0.000158	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	3.78e-05	0.000157	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CD80—multiple sclerosis	3.77e-05	0.000157	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MMP9—multiple sclerosis	3.7e-05	0.000154	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CD80—multiple sclerosis	3.69e-05	0.000153	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	3.68e-05	0.000153	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	3.66e-05	0.000152	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—POMC—multiple sclerosis	3.61e-05	0.00015	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—POMC—multiple sclerosis	3.61e-05	0.00015	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—POMC—multiple sclerosis	3.58e-05	0.000149	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CCL2—multiple sclerosis	3.53e-05	0.000147	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CCL2—multiple sclerosis	3.53e-05	0.000147	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	3.52e-05	0.000146	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—POMC—multiple sclerosis	3.51e-05	0.000146	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	3.51e-05	0.000146	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	3.5e-05	0.000145	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—STAT3—multiple sclerosis	3.49e-05	0.000145	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	3.47e-05	0.000144	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CD80—multiple sclerosis	3.47e-05	0.000144	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	3.46e-05	0.000144	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—MAPK1—multiple sclerosis	3.45e-05	0.000143	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	3.43e-05	0.000143	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	3.43e-05	0.000143	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	3.42e-05	0.000142	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	3.4e-05	0.000141	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	3.37e-05	0.00014	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	3.36e-05	0.00014	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	3.35e-05	0.000139	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	3.35e-05	0.000139	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CD86—multiple sclerosis	3.33e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	3.33e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—POMC—multiple sclerosis	3.3e-05	0.000137	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—STAT3—multiple sclerosis	3.29e-05	0.000137	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	3.28e-05	0.000136	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MYC—multiple sclerosis	3.24e-05	0.000135	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TGFB1—multiple sclerosis	3.23e-05	0.000134	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	3.23e-05	0.000134	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TYK2—multiple sclerosis	3.21e-05	0.000133	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TYK2—multiple sclerosis	3.2e-05	0.000133	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	3.18e-05	0.000132	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	3.18e-05	0.000132	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MAPK1—multiple sclerosis	3.17e-05	0.000132	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	3.16e-05	0.000131	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	3.12e-05	0.00013	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOE—multiple sclerosis	3.11e-05	0.000129	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOE—multiple sclerosis	3.1e-05	0.000129	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MYC—multiple sclerosis	3.06e-05	0.000127	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TGFB1—multiple sclerosis	3.05e-05	0.000127	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	3.04e-05	0.000126	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MAPK1—multiple sclerosis	2.99e-05	0.000124	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	2.95e-05	0.000123	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	2.93e-05	0.000122	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	2.91e-05	0.000121	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	2.89e-05	0.00012	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CD80—multiple sclerosis	2.81e-05	0.000117	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CD80—multiple sclerosis	2.8e-05	0.000116	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOE—multiple sclerosis	2.69e-05	0.000112	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—POMC—multiple sclerosis	2.67e-05	0.000111	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL2—multiple sclerosis	2.67e-05	0.000111	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL2—multiple sclerosis	2.67e-05	0.000111	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—POMC—multiple sclerosis	2.66e-05	0.00011	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—multiple sclerosis	2.66e-05	0.00011	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—multiple sclerosis	2.65e-05	0.00011	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL2—multiple sclerosis	2.65e-05	0.00011	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	2.64e-05	0.00011	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	2.62e-05	0.000109	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	2.6e-05	0.000108	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL2—multiple sclerosis	2.59e-05	0.000108	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	2.58e-05	0.000107	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.56e-05	0.000106	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	2.55e-05	0.000106	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MMP9—multiple sclerosis	2.53e-05	0.000105	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MMP9—multiple sclerosis	2.52e-05	0.000105	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	2.51e-05	0.000104	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	2.46e-05	0.000102	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL2—multiple sclerosis	2.44e-05	0.000101	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—multiple sclerosis	2.44e-05	0.000101	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CD80—multiple sclerosis	2.43e-05	0.000101	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	2.42e-05	0.000101	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	2.37e-05	9.87e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	2.36e-05	9.82e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—POMC—multiple sclerosis	2.31e-05	9.59e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	2.31e-05	9.58e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—multiple sclerosis	2.3e-05	9.54e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	2.26e-05	9.39e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—STAT3—multiple sclerosis	2.25e-05	9.33e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—STAT3—multiple sclerosis	2.24e-05	9.32e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	2.23e-05	9.26e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	2.21e-05	9.19e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	2.18e-05	9.07e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MYC—multiple sclerosis	2.09e-05	8.67e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MYC—multiple sclerosis	2.09e-05	8.66e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	2.08e-05	8.65e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	2.08e-05	8.64e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MYC—multiple sclerosis	2.07e-05	8.61e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	2.07e-05	8.59e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	2.05e-05	8.52e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	2.05e-05	8.52e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	2.04e-05	8.48e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	2.04e-05	8.48e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MYC—multiple sclerosis	2.03e-05	8.43e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	2.03e-05	8.42e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	2.02e-05	8.41e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	1.98e-05	8.24e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL2—multiple sclerosis	1.98e-05	8.21e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	1.97e-05	8.17e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL2—multiple sclerosis	1.97e-05	8.17e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	1.96e-05	8.13e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MYC—multiple sclerosis	1.91e-05	7.92e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	1.9e-05	7.9e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	1.87e-05	7.77e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	1.86e-05	7.74e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	1.86e-05	7.73e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL2—multiple sclerosis	1.71e-05	7.09e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	1.7e-05	7.06e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	1.66e-05	6.91e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	1.65e-05	6.87e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	1.62e-05	6.71e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—multiple sclerosis	1.57e-05	6.52e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—multiple sclerosis	1.57e-05	6.51e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—multiple sclerosis	1.56e-05	6.47e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MYC—multiple sclerosis	1.55e-05	6.42e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	1.54e-05	6.4e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MYC—multiple sclerosis	1.54e-05	6.39e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	1.53e-05	6.37e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—multiple sclerosis	1.52e-05	6.34e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	1.51e-05	6.28e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	1.5e-05	6.25e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	1.44e-05	5.97e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—multiple sclerosis	1.43e-05	5.95e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MYC—multiple sclerosis	1.33e-05	5.55e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	1.33e-05	5.53e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	1.31e-05	5.43e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—multiple sclerosis	1.16e-05	4.83e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—multiple sclerosis	1.16e-05	4.8e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—multiple sclerosis	1e-05	4.17e-05	CbGpPWpGaD
